Cancer Research Institute

12/19/2025

🌟 At CRI, impact is about more than numbers. Every grant, fellowship, and clinical trial represents lives touched, families strengthened, and futures reshaped.

Understand how CRI is turning investment into innovation, in our Annual Impact Report:

30+ cancer types, 9 million patients, $570M invested. See how CRI makes an impact in cancer treatment worldwide.

12/18/2025

The Cancer Research Institute is honored to share the Winter 2025 CRI Irvington Postdoctoral Fellows and Immuno-Informatics Postdoctoral Fellows. These outstanding scientists are advancing pioneering work across tumor immunology, computational biology, and cellular engineering. Their research reflects the urgency, innovation, and collaboration required to transform cancer care.

Meet the Postdoctoral Fellows: https://bit.ly/45aNyET

Discover how the Cancer Research Institute's postdoctoral fellowship program is advancing cancer immunotherapy by supporting early-career scientists around the world with funding, mentorship, and training in both immunology and bioinformatics.

12/18/2025

🌟 "When I heard the word 'immunotherapy,' and there was a chance for more time, that sparked something in me," describes Oswald, a stage 4 lung cancer survivor.

Discover how immunotherapy gave Oswald more hope, and more time: https://bit.ly/4oH4kCA

12/17/2025

How can you maximize your deduction, and multiply your impact with the Cancer Research Institute? Understand how you can make every dollar count, before year end, in our new blog: https://bit.ly/493xNAV

Supporters are reaching out, seeking to understand the combined impact of changes to federal funding for cancer research and shifts in tax law, and how best to navigate this moment to maximize their impact for the Cancer Research Institute (CRI).

12/17/2025

Diagnosed with stage 4 lung cancer, Oswald found hope through immunotherapy. Just two weeks after his first treatment, his tumors began to shrink. Six months later, he was declared cancer-free.

Breakthroughs like this are possible because of scientific discovery supported by CRI. Show your support today, and spread hope to patients everywhere: https://bit.ly/4oKA5vh

12/16/2025

🧡 At CRI, patients aren’t just central to our mission- they’re the reason it matters.
Our research has already extended survival worldwide, contributing tens of millions of healthy “life-years” and touching an estimated 250 million lives since the first immunotherapy approvals.

Dive deeper into our impact on patients, in our 2025 Annual Impact Report:

30+ cancer types, 9 million patients, $570M invested. See how CRI makes an impact in cancer treatment worldwide.

12/15/2025

After a devastating diagnosis, dancer Oswald Peterson found his rhythm again, and a new reason to celebrate life, thanks to immunotherapy. Discover his story: https://bit.ly/3LRHEBP

12/14/2025

Across the country, federal funding cuts are disrupting cancer research. Grants are delayed, labs are scaling back or shutting down, and early-career scientists are at risk of leaving the field entirely.

📝 At CRI, we’ve seen the effects firsthand: grant applications from researchers who have nowhere else to turn have doubled.

These are the researchers who could drive the next breakthroughs in cancer treatment. Their careers hang in the balance.

🤝 CRI is committed to meeting this urgent need, but we cannot do this alone. Your partnership matters now more than ever.

Make your gift today to ensure this promising research keeps moving forward, so it can save more lives: https://bit.ly/4oKA5vh

12/13/2025

“Every morning I get to wake up is a day I was not supposed to have," describes Oswald, a stage 4 lung cancer survivor.

Watch Oswald's full story here: https://bit.ly/4oH4kCA

12/12/2025

The Nature’s 10 list "highlights some of the most influential research and important developments shaping our world." Meet 10 people who helped shape science in 2025, including CRI Lloyd J. Old STAR Dr. Yifat Merbl of Weizmann Institute of Science:

Yifat Merbl is part of Nature’s 10, a list of people who shaped science in 2025.

12/11/2025

In 2017, Oswald was diagnosed with stage 4 non-small cell lung cancer. After just two infusions of the immunotherapy checkpoint inhibitor, Keytruda (pembrolizumab), scans showed that the cancer had shrunk dramatically.

Watch Oswald's full story here: https://youtu.be/_FACxuC9czs

12/10/2025

"November 2025 was a landmark month for oncology, characterized by a wave of pivotal regulatory decisions from the FDA that promise to reshape the treatment landscape across numerous cancer types," Targeted Oncology describes. Dive into key regulatory milestones, and explore new approvals from this month: https://bit.ly/4pipTdM

November 2025 marks a transformative month for oncology, featuring groundbreaking FDA approvals that enhance treatment options across various cancer types.